ArticleJournal of cardiovascular development and disease2023

Feasibility of Short-Term Aggressive Lipid-Lowering Therapy with the PCSK9 Antibody in Acute Coronary Syndrome.

Satoshi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.